These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1667481)
21. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S; Saï P; Bach JM Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293 [TBL] [Abstract][Full Text] [Related]
22. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823 [TBL] [Abstract][Full Text] [Related]
23. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity. Zucali JR; Morse C; Dinarello CA Exp Hematol; 1990 Sep; 18(8):888-92. PubMed ID: 2167234 [TBL] [Abstract][Full Text] [Related]
24. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells. Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714 [TBL] [Abstract][Full Text] [Related]
25. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines. Walter H; Schepensn S; Van Wauwe J; de Boer M Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453 [TBL] [Abstract][Full Text] [Related]
26. Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1. Campbell IK; Novak U; Cebon J; Layton JE; Hamilton JA J Immunol; 1991 Aug; 147(4):1238-46. PubMed ID: 1714478 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Arnold R; Humbert B; Werchau H; Gallati H; König W Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169 [TBL] [Abstract][Full Text] [Related]
28. Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus. Sherr CJ; Fedele LA; Oskarsson M; Maizel J; Vande Woude G J Virol; 1980 Apr; 34(1):200-12. PubMed ID: 6246254 [TBL] [Abstract][Full Text] [Related]
29. Translational products encoded by newly acquired sequences of independently derived feline sarcoma virus isolates are structurally related. Van de Ven WJ; Khan AS; Reynolds FH; Mason KT; Stephenson JR J Virol; 1980 Mar; 33(3):1034-45. PubMed ID: 6245259 [TBL] [Abstract][Full Text] [Related]
30. In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus. Pierce JH; Aaronson SA J Virol; 1983 Jun; 46(3):993-1002. PubMed ID: 6304354 [TBL] [Abstract][Full Text] [Related]
31. Three sizes of subunits in RNAs from feline sarcoma-leukaemia virus mixtures. Kimball PC; Rea TJ J Gen Virol; 1980 Dec; 51(Pt 2):295-305. PubMed ID: 6262439 [TBL] [Abstract][Full Text] [Related]
32. Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation. Reynolds FH; Van de Ven WJ; Blomberg J; Stephenson JR J Virol; 1981 Feb; 37(2):643-53. PubMed ID: 6261011 [TBL] [Abstract][Full Text] [Related]
33. Transformation-defective mutants of Snyder-Theilen feline sarcoma virus lack tyrosine-specific protein kinase activity. Barbacid M; Donner L; Ruscetti SK; Sherr CJ J Virol; 1981 Jul; 39(1):246-54. PubMed ID: 6168771 [TBL] [Abstract][Full Text] [Related]
34. Structure and origins of the HZ2-feline sarcoma virus. Bergold PJ; Wang JY; Hardy WD; Littau V; Johnson E; Besmer P Virology; 1987 Jun; 158(2):320-9. PubMed ID: 2884777 [TBL] [Abstract][Full Text] [Related]
35. Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene. Donner L; Turek LP; Ruscetti SK; Fedele LA; Sherr CJ J Virol; 1980 Jul; 35(1):129-40. PubMed ID: 6251261 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus. Barbacid M; Lauver AV; Devare SG J Virol; 1980 Jan; 33(1):196-207. PubMed ID: 6154148 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus. Azocar J; Essex M J Natl Cancer Inst; 1979 Nov; 63(5):1179-84. PubMed ID: 228103 [TBL] [Abstract][Full Text] [Related]
39. Recombinant bacteriophages containing the integrated transforming provirus of Gardner--Arnstein feline sarcoma virus. Fedele LA; Even J; Garon CF; Donner L; Sherr CJ Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4036-40. PubMed ID: 6270655 [TBL] [Abstract][Full Text] [Related]
40. Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus. Barbacid M; Beemon K; Devare SG Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5158-62. PubMed ID: 6254060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]